Cargando…

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial

PURPOSE: Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spare adjacent critical organs, improving toxicity profiles and potentially improving clinical outcomes. METHODS AND MATERIALS: We evaluated the REG001-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parzen, Jacob S., Chuong, Michael D., Chang, John, Rosen, Lane, Urbanic, James, Hartsell, William, Tsai, Henry, Sinesi, Christopher, Zeng, Jing, Mishra, Mark, Vargas, Carlos, Stevens, Craig, Kabolizadeh, Peyman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498730/ https://www.ncbi.nlm.nih.gov/pubmed/34646969 http://dx.doi.org/10.1016/j.adro.2021.100751

Ejemplares similares

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
por: Parzen, Jacob S., et al.
Publicado: (2020)

Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09
por: Mishra, Mark V., et al.
Publicado: (2020)

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
por: Mishra, Mark V., et al.
Publicado: (2019)

Optimization of Field Design in the Treatment of Rectal Cancer with Intensity Modulated Proton Beam Radiation Therapy: How Many Fields Are Needed to Account for Rectal Distension Uncertainty?
por: Parzen, Jacob S., et al.
Publicado: (2021)

Proton Therapy for Skull-Base Chordomas and Chondrosarcomas: Initial Results From the Beaumont Proton Therapy Center
por: Parzen, Jacob S, et al.
Publicado: (2021)

Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry
por: Jongen, Aurélien, et al.
Publicado: (2021)

Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry
por: Saeed, Ali M., et al.
Publicado: (2020)

Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry
por: Han, James E., et al.
Publicado: (2020)

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
por: Eckstein, Jacob, et al.
Publicado: (2023)

Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial
por: Choi, J. Isabelle, et al.
Publicado: (2022)

Redefine the role of range shifter in treating bilateral head and neck cancer in the era of Intensity Modulated Proton Therapy
por: Ding, Xuanfeng, et al.
Publicado: (2018)

Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022)

A magic cube for proton/ion dosimetry
por: Brusasco, C, et al.
Publicado: (1995)

Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study
por: Liu, Gang, et al.
Publicado: (2020)

Linear Energy Transfer Incorporated Spot-Scanning Proton Arc Therapy Optimization: A Feasibility Study
por: Li, Xiaoqiang, et al.
Publicado: (2021)

The Tsallis Distribution in Proton-Proton Collisions at $\sqrt{s}$ = 0.9 TeV at the LHC
por: Cleymans, J., et al.
Publicado: (2011)

Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy
por: Li, Xiaoqiang, et al.
Publicado: (2018)

Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy
por: Chang, Sheng, et al.
Publicado: (2020)

Dosimetry of medical proton beams at the JINR phasotron in Dubna
por: Kovar, I, et al.
Publicado: (1993)

Megarad dosimetry techniques used at the CERN Proton Synchrotron
por: Madsen, JHB, et al.
Publicado: (1968)

A new silicon tracker for proton imaging and dosimetry
por: Taylor, J.T., et al.
Publicado: (2016)

Medium-thickness-dependent proton dosimetry for radiobiological experiments
por: Shahmohammadi Beni, Mehrdad, et al.
Publicado: (2019)

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer
por: Vargas, Carlos E., et al.
Publicado: (2018)

Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region – Data From the Prospective Registries ProReg and KiProReg
por: Worawongsakul, Rasin, et al.
Publicado: (2022)

Strange particle production in proton-proton collisions at $\sqrt{s}$ = 0.9 TeV with ALICE at the LHC
por: Aamodt, K., et al.
Publicado: (2010)

Multiplicity measurements in proton--proton collisions at $\sqrt{s}$ = 0.9 and 2.36 TeV with ALICE
por: Grosse-Oetringhaus, Jan Fiete
Publicado: (2010)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Dosimetry in radiation fields around high-energy proton accelerators
por: Agosteo, S, et al.
Publicado: (2007)

Absolute dosimetry for FLASH proton pencil beam scanning radiotherapy
por: Lourenço, Ana, et al.
Publicado: (2023)

General Purpose Transistor Characterized as Dosimetry Sensor of Proton Beams
por: Moreno-Pérez, J. A., et al.
Publicado: (2023)

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration
por: Baron, Jonathan A., et al.
Publicado: (2022)

Charged–particle multiplicities in proton–proton collisions at $\sqrt{s}=$ 0.9 to 8 TeV, with ALICE at the LHC
por: Adam, Jaroslav, et al.
Publicado: (2015)

Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry
por: Jazmati, Danny, et al.
Publicado: (2021)

Preclinical dosimetry in proton minibeam radiation therapy: Robustness analysis and guidelines
por: Ortiz, Ramon, et al.
Publicado: (2022)

Analysis of patient outcomes following proton radiation therapy for retinoblastoma
por: Mouw, Kent W., et al.
Publicado: (2016)

Multiple Computed Tomography Robust Optimization to Account for Random Anatomic Density Variations During Intensity Modulated Proton Therapy
por: Zhu, Mingyao, et al.
Publicado: (2019)

Charged-particle multiplicity measurement in proton-proton collisions at $\sqrt{s}$ = 0.9 and 2.36 TeV with ALICE at LHC
por: Aamodt, K., et al.
Publicado: (2010)

Inclusive photon production at forward rapidities in proton-proton collisions at $\sqrt{s}$ = 0.9, 2.76 and 7 TeV
por: Abelev, Betty Bezverkhny, et al.
Publicado: (2014)

Structural basis for polyspecificity in the POT family of proton-coupled oligopeptide transporters
por: Lyons, Joseph A, et al.
Publicado: (2014)

The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy
por: Henjum, Helge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pf4c4onnui0ommv20500ih5g1o